GORE? VIATORR? TIPS ENDOPROSTHESIS PTB8108275

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2018-05-11 for GORE? VIATORR? TIPS ENDOPROSTHESIS PTB8108275 manufactured by W.l. Gore & Associates.

Event Text Entries

[107985860] A review of the manufacturing records for the device verified that the lot met all pre-release specifications. The device remains implanted so no engineering investigation could be performed. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[107985862] It was reported that the physician was implanting a gore? Viatorr? Tips endoprosthesis with controlled expansion for a transjugular intrahepatic portosystemic shunt (tips) procedure. The patient presented with non occlusive portal vein thrombosis prior to tips implantation. The device was deployed to 8mm. According to the physician, the device appeared to completely cover the hepatic vein to the inferior vena cava on ct. The device was deployed and implanted without incident. The physician brought the patient in for a one-week follow up. The physician did not see any flow through the device under ultrasound and thought it may just be due to the wet-out of the ptfe device. The patient was brought back in due to worsened ascites and to re-do the ultrasound one week later (two weeks post implant) and the physician could still not see any flow through the device under ultrasound. Thrombosis of the device was suspected. The physician performed a venogram to determine the patency of the device. The venogram showed that the stent and portal vein had thrombosed and also showed thrombus in the smv. The physician is planning for the patient to get lysed overnight. After the patient was lysed, the patient came back for thrombectomy (angio jet, boston scientific). The physician dilated the viatorr cx stent and relined half of the viatorr cx with a covered stent and extended into the ivc. The physician lined the portal vein with a bare metal stent. The physician reports that the patient did very well. The patient was put on anticoagulants for 6 months. The physician stated that he can't say for sure that the thrombus was due to the device because there was preexisting portal vein thrombosis.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007284313-2018-00149
MDR Report Key7506371
Report SourceCOMPANY REPRESENTATIVE
Date Received2018-05-11
Date of Report2018-04-13
Date of Event2018-04-03
Device Manufacturer Date2018-02-03
Date Added to Maude2018-05-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactASHLEY MAROSTICA
Manufacturer Street1500 N. 4TH STREET
Manufacturer CityFLAGSTAFF AZ
Manufacturer Phone9285263030
Manufacturer G1MEDICAL PHOENIX 1 B/P
Manufacturer Street32360 N. NORTH VALLEY PARKWAY
Manufacturer CityPHOENIX AZ 85085
Manufacturer CountryUS
Manufacturer Postal Code85085
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameGORE? VIATORR? TIPS ENDOPROSTHESIS
Generic NameSHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS
Product CodeMIR
Date Received2018-05-11
Catalog NumberPTB8108275
Lot Number17738999
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerW.L. GORE & ASSOCIATES
Manufacturer AddressFLAGSTAFF AZ


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-05-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.